|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.380 USD | +1.15% |
|
+1.86% | +29.97% |
| Market Cap | 721M 631M 582M 540M 1.03B 68.78B 1.04B 6.96B 2.71B 33.76B 2.71B 2.65B 117B | P/E 2026 * |
3.71x | P/E 2027 * | 3.55x |
|---|---|---|---|---|---|
| Enterprise Value | 721M 631M 582M 540M 1.03B 68.78B 1.04B 6.96B 2.71B 33.76B 2.71B 2.65B 117B | EV / Sales 2026 * |
1.57x | EV / Sales 2027 * | 1.51x |
| Free-Float |
96.84% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ironwood Pharmaceuticals, Inc.
| 1 day | +1.15% | ||
| 1 week | +1.86% | ||
| Current month | +4.04% | ||
| 1 month | +32.33% | ||
| 3 months | +24.08% | ||
| 6 months | +1.86% | ||
| Current year | +29.97% |
| 1 week | 4.06 |  | 4.47 |
| 1 month | 3.14 | | 4.47 |
| Current year | 2.95 | | 5.78 |
| 1 year | 0.67 | | 5.78 |
| 3 years | 0.53 | | 15.7 |
| 5 years | 0.53 | | 15.7 |
| 10 years | 0.53 | | 21.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 68 | 11/03/2021 |
Ronald Silver
DFI | Director of Finance/CFO | 44 | 14/05/2026 |
Rosario Lobrutto
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
BRD | Director/Board Member | 68 | 03/06/2021 |
Julie McHugh
CHM | Chairman | 61 | 31/03/2019 |
Marla Kessler
BRD | Director/Board Member | 56 | 31/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-15 | Free | Director | 63,481 | 0.0386% | ||
| 06-15 | Free | Director | 63,481 | 0.0386% | ||
| 06-15 | Free | Chairman | 85,052 | 0.0517% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.15% | +1.86% | +471.80% | -56.50% | 721M | |
| -2.15% | -2.01% | +56.65% | +13.45% | 313B | |
| +0.47% | -2.38% | +31.09% | -2.15% | 70.89B | |
| +1.67% | +4.66% | +49.59% | +120.65% | 9.58B | |
| -0.77% | +4.93% | +8.41% | +3.43% | 8.82B | |
| -5.79% | +6.58% | +18.45% | +30.79% | 4.25B | |
| -2.55% | -7.79% | -8.10% | +8.11% | 4.29B | |
| -1.14% | -5.69% | -34.65% | +26.00% | 3.39B | |
| -1.69% | +0.94% | +47.72% | +59.97% | 2.74B | |
| +1.66% | +1.88% | +17.18% | -19.63% | 2.22B | |
| Average | -1.06% | +3.54% | +65.82% | +18.41% | 42B | |
| Weighted average by Cap. | -1.63% | +2.44% | +49.83% | +13.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 459M 402M 371M 344M 653M 43.83B 662M 4.44B 1.73B 21.51B 1.73B 1.69B 74.59B | 478M 419M 386M 358M 680M 45.63B 689M 4.62B 1.8B 22.4B 1.8B 1.76B 77.65B |
| Net income | 188M 165M 152M 141M 268M 17.96B 271M 1.82B 707M 8.81B 707M 691M 30.56B | 210M 184M 169M 157M 298M 20.02B 302M 2.03B 789M 9.83B 788M 771M 34.07B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | US$4.380 | +1.15% | 3,001,622 |
| 02/07/26 | US$4.330 | +5.10% | 2,651,198 |
| 01/07/26 | US$4.120 | -2.14% | 1,653,028 |
| 30/06/26 | US$4.210 | -2.09% | 2,586,091 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRWD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
